The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types

Abstract

A novel variant of the SARS-CoV-2 virus carrying a point mutation in the Spike protein (D614G) has recently emerged and rapidly surpassed others in prevalence. This mutation is in linkage disequilibrium with an ORF1b protein variant (P314L), making it difficult to discern the functional significance of the Spike D614G mutation from population genetics alone. Here, we perform site-directed mutagenesis on wild-type human-codon-optimized Spike to introduce the D614G variant. Using multiple human cell lines, including human lung epithelial cells, we found that the lentiviral particles pseudotyped with Spike D614G are more effective at transducing cells than ones pseudotyped with wild-type Spike. The increased transduction with Spike D614G ranged from 1.3- to 2.4-fold in Caco-2 and Calu-3 cells expressing endogenous ACE2 and from 1.5- to 7.7-fold in A549 ACE2 and Huh7.5 ACE2 overexpressing ACE2. Furthermore, trans -complementation of SARS-CoV-2 virus with Spike D614G showed an increased infectivity in human cells. Although there is minimal difference in ACE2 receptor binding between the D614 and G614 Spike variants, the G614 variant is more resistant to proteolytic cleavage, suggesting a possible mechanism for the increased transduction.

Cited by papers we hold 10

• Emergence of a novel SARS-CoV-2 Pango lineage B.1.1.526 in West Bengal, India · 2022
  Not checked
• A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations · 2022
  No notice
• SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia · 2021
  Not checked
• Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates · 2021
  Not checked
• Wuhan to World: The COVID-19 Pandemic · 2021
  No notice
• SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity · 2021
  No notice
• SARS-CoV-2 one year on: evidence for ongoing viral adaptation · 2021
  No notice
• The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways · 2021
  No notice
• Distinct conformational states of SARS-CoV-2 spike protein · 2020
  No notice
• SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.